Krka Sees Profit, Sales in Western Europe Soar
Ljubljana, 31 August - Pharmaceutical group Krka has reported a half-year net profit of SIT 8.3bn (EUR 34.6m), which is 65 percent more than in the same period last year. The Novo mesto-based group's revenues grew by 22 percent to SIT 58.1bn (EUR 242.3m).
The rest of this news item is available to subscribers.
The news item consists of 708 characters (without spaces) or 135 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.